Table of Contents

company-logo

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. It has a strategic partnership with GTP Biologics and VBI Therapeutics Group for the bioproduction of the bio-HDL in France. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.

ABIONYX Pharma Dividend Announcement

• ABIONYX Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on ABIONYX Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

ABIONYX Pharma Dividend History

ABIONYX Pharma Dividend Yield

ABIONYX Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing ABIONYX Pharma stock? Use our calculator to estimate your expected dividend yield:

ABIONYX Pharma Financial Ratios

P/E ratio-7.80
PEG ratio-0.74
P/B ratio4.69
ROE-75.15%
Payout ratio0.00%
Current ratio2.28
Quick ratio2.22
Cash Ratio1.60

ABIONYX Pharma Dividend FAQ

Does ABIONYX Pharma stock pay dividends?
ABIONYX Pharma does not currently pay dividends to its shareholders.
Has ABIONYX Pharma ever paid a dividend?
No, ABIONYX Pharma has no a history of paying dividends to its shareholders. ABIONYX Pharma is not known for its dividend payments.
Why doesn't ABIONYX Pharma pay dividends?
There are several potential reasons why ABIONYX Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will ABIONYX Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While ABIONYX Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is ABIONYX Pharma a dividend aristocrat?
ABIONYX Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is ABIONYX Pharma a dividend king?
ABIONYX Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is ABIONYX Pharma a dividend stock?
No, ABIONYX Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy ABIONYX Pharma stocks?
To buy ABIONYX Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy ABIONYX Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.